Objective: To report the FDA approval of enlicitide (LIPFENDRA) for reducing LDL cholesterol in adults with hypercholesterolemia. Approach: Approval Details: En
The FDA has approved enlicitide (LIPFENDRA) as the first oral PCSK9 inhibitor for adults with hypercholesterolemia.
Enlicitide is indicated as an adjunct to diet and exercise for reducing low-density lipoprotein cholesterol.
The approval was based on results from the phase 3 CORALreef Lipids and CORALreef HeFH trials.
In these trials, enlicitide demonstrated significant reductions in LDL-C and other lipid parameters compared to placebo.
Adverse reactions were similar between enlicitide and placebo groups, with diarrhea and dizziness reported more frequently in enlicitide-treated patients.
Objective: To discuss the implications of a proposed constitutional amendment in Missouri that could lead to sales taxes on healthcare services and prescription
Objective: To examine the independent associations of prolonged and interrupted sedentary behavior with cancer risk among UK Biobank participants. Approach: Stu
Prolonged sedentary bouts were linked to higher risks of developing and dying from cancer among 91,292 UK Biobank participants.
Sedentary time in shorter, interrupted bouts was associated with lower cancer risk, according to a prospective cohort study.
Each additional hour of prolonged sedentary behavior increased cancer mortality and incidence, while interrupted sedentary behavior decreased those risks.
Replacing prolonged sedentary behavior with physical activity was linked to lower cancer risks, especially with vigorous-intensity activity.
The study identified methodological limitations, including measurement imprecision and the inability to establish causality.
Objective: To develop a comprehensive dataset for anterior segment eye disease to enhance research into conditions affecting the front of the eye. Approach: Dat
Objective: To capture the experiences of thousands of people living with or being monitored for glaucoma through the largest patient insight survey in the UK. A
Objective: To discuss the challenges in Ebola diagnostics and the implications of the current outbreak in the Democratic Republic of the Congo, with insights fr
Objective: To explore the development of a low-cost electrochemical sensor for measuring dopamine in tears as a noninvasive method for monitoring neurological b
Objective: To evaluate the effectiveness of minimally invasive arthroscopic treatment for coracoid process fractures. Approach: Study Design: Retrospective stud
Objective: To understand patients’ current pharmacologic and non-pharmacologic SCD management practices and explore their perspectives on pain related to SCD. A
Objective: To evaluate the immunomodulatory properties of six adjuvants formulated with recombinant VZV glycoprotein E in a mouse model of herpes zoster. Approa
Objective: To characterize resting-state EEG microstate dynamics in adolescents with non-suicidal self-injury (NSSI) and examine state-dependent changes followi
Objective: To explore the role of ATP-binding cassette (ABC) transporters in maintaining fetal metabolic homeostasis and their dysfunction in various obstetric
ABC transporters are active efflux proteins that regulate fetal metabolic homeostasis and chemical exposure during pregnancy.
The maternal-fetal interface utilizes ABC transporters to block harmful substances while facilitating nutrient transport to the fetus.
Dysfunction of ABC transporters is implicated in obstetric complications such as preeclampsia, gestational diabetes, and preterm birth.
Recent advances in cryo-electron microscopy and single-cell transcriptomics enhance understanding of ABC transporter roles in pregnancy.
Clinical pharmacogenomics opportunities include genotyping ABCG2 for glyburide prescribing in gestational diabetes and ABCB4 profiling for cholestasis risk.
Objective: To identify PD-1/PD-L1 and CTLA-4/CD80 interaction states as enhanced predictive biomarkers for patient stratification to anti-PD-1/PD-L1 therapies i
Objective: To assess the effect of oral magnesium supplementation on glycated hemoglobin (HbA1c) and metabolic biomarkers in adults with Type 2 Diabetes Mellitu
Objective: To propose a novel framework, VesselMetaKAN, for robust and interpretable classification of diabetic retinopathy (DR) by integrating vessel guidance
Objective: To investigate the relationship between the triglyceride-glucose (TyG) index and 2-year major adverse cardiovascular events (MACE) in individuals wit
The study involved 1,024 individuals with essential hypertension and obstructive coronary artery disease treated at The Affiliated Hospital of Qingdao University.
After 2 years, 19.73% of patients experienced major adverse cardiovascular events, with a significant link to the triglyceride-glucose index.
Each one-unit increase in the triglyceride-glucose index was associated with a 45.2% increased risk of major adverse cardiovascular events.
Subgroup analysis confirmed the triglyceride-glucose index's consistent predictive performance across different patient groups.
Mendelian randomization analysis indicated a significant causal relationship between elevated triglyceride-glucose index and adverse cardiovascular outcomes.
Objective: To evaluate the mechanistic pathways underlying both pro-tumour and anti-tumour effects of parasites or parasite-derived products across different ex
Objective: To summarize current knowledge regarding the origin, composition, phenotype, and dynamics of human epidermal TRM cells. Approach: Review of Literatur